ARMLUPEG DIN 02550857
Health Canada record
| Active ingredient(s) | PEGFILGRASTIM 6 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION; SCHEDULE D |
| Class | Human |
| ATC | L03AA13 PEGFILGRASTIM |
| Original market date | |
| Current status date | 16-Aug-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Lupin Pharma Canada Limited — licence 102119, currently licensed, last inspection rating C (2025-07-22).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PEGFILGRASTIM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02564394 | DYRUPEG | CURATEQ BIOLOGICS PRIVATE LIMITED | Solution | PEGFILGRASTIM 6 MG | Approved |
| 02484153 | FULPHILA | BIOCON BIOLOGICS CANADA INC | Solution | PEGFILGRASTIM 10 MG | Marketed |
| 02529343 | LAPELGA | APOTEX INC | Solution | PEGFILGRASTIM 6 MG | Marketed |
| 02474565 | LAPELGA | APOTEX INC | Solution | PEGFILGRASTIM 6 MG | Marketed |
| 02249790 | NEULASTA | AMGEN CANADA INC | Solution | PEGFILGRASTIM 10 MG | Marketed |
| 02546973 | NIOPEG | NORA PHARMA INC | Solution | PEGFILGRASTIM 6 MG | Marketed |
| 02506238 | NYVEPRIA | PFIZER CANADA ULC | Solution | PEGFILGRASTIM 6 MG | Marketed |
| 02553945 | PEXEGRA | JAMP PHARMA CORPORATION | Solution | PEGFILGRASTIM 10 MG | Marketed |
| 02497395 | ZIEXTENZO | SANDOZ CANADA INCORPORATED | Solution | PEGFILGRASTIM 6 MG | Marketed |